Staphylococcus aureus, a major human pathogen, has a collection of virulence factors and
the ability to acquire resistance to most antibiotics. This ability is further augmented by …

The Staphylococcus aureus enterotoxins are a superfamily of secreted virulence factors that
share structural and functional similarities and possess potent superantigenic activity …

The spread of antibiotic resistance is attracting increased attention to combination-based
treatments. Although drug combinations have been studied extensively for their effects on …

Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs),
endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign …

During infection, inflammatory monocytes are thought to be key for bacterial eradication, but
this is hard to reconcile with the large numbers of neutrophils that are recruited for each …

Staphylococcus aureus produces a wide variety of toxins including staphylococcal
enterotoxins (SEs; SEA to SEE, SEG to SEI, SER to SET) with demonstrated emetic activity …

Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and
causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in …

In recent years, methicillin-resistant Staphylococcus aureus (MRSA) have become a truly
global challenge. In addition to the long-known healthcare-associated clones, novel strains …

S. aureus infections in intensive care units in the National Nosocomial Infections
Surveillance System. Data include the total number of infections from 1987 to 1997. Isolates …

Bone and joint infections are painful for patients and frustrating for both them and their
doctors. The high success rates of antimicrobial therapy in most infectious diseases have not …